A detailed history of First Affirmative Financial Network transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Affirmative Financial Network holds 953 shares of VRTX stock, worth $462,671. This represents 0.31% of its overall portfolio holdings.

Number of Shares
953
Previous 943 1.06%
Holding current value
$462,671
Previous $394,000 13.2%
% of portfolio
0.31%
Previous 0.3%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$392.81 - $485.53 $3,928 - $4,855
10 Added 1.06%
953 $446,000
Q1 2024

Apr 11, 2024

SELL
$407.69 - $446.08 $407 - $446
-1 Reduced 0.11%
943 $394,000
Q4 2023

Jan 08, 2024

BUY
$343.0 - $410.68 $71,344 - $85,421
208 Added 28.26%
944 $384,000
Q3 2023

Oct 16, 2023

BUY
$338.18 - $362.46 $44,639 - $47,844
132 Added 21.85%
736 $255,000
Q2 2023

Jul 10, 2023

BUY
$314.42 - $351.91 $189,909 - $212,553
604 New
604 $212,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $125B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track First Affirmative Financial Network Portfolio

Follow First Affirmative Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Affirmative Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on First Affirmative Financial Network with notifications on news.